Multiparametric ultrasound for non-invasive assessment of liver steatosis, fibrosis, and inflammation in metabolic dysfunction-associated steatotic liver disease

Figure 3 Performance of non-invasive diagnostic tests (transient elastography, two-dimensional shear wave elastography, viscosity plane-wave ultrasound, nonalcoholic fatty liver disease fibrosis score, Agile3 +, and fibrosis-4) for predicting significant fibrosis and advanced fibrosis. A and B: Receiver operating characteristic curves for the performance of non-invasive diagnostic tests (transient elastography, two-dimensional shear wave elastography, viscosity plane-wave ultrasound, nonalcoholic fatty liver disease fibrosis score, Agile3 +, and fibrosis-4) in the detection of significant fibrosis (A) or advanced fibrosis (B). 2D-SWE: Two-dimensional shear wave elastography; Vi.PLUS: Viscosity plane-wave ultrasound; Fib-4: Fibrosis-4; NFS: Nonalcoholic fatty liver disease fibrosis score; LSM: Liver stiffness measurement.